Some of the most significant support has come from the Corporate Roundtable, a dynamic partnership between the Foundation and industry leaders that provides a forum for dialogue. As part of the Corporate Roundtable and a Leadership level donor, AbbVie has been a major supporter of the Foundation for several years. The company’s generous contributions to the campaign have helped push the fundraising ahead of schedule.
The Journey to Cure campaign has been quite a success so far. … Some of the most significant support has come from the Corporate Roundtable, a dynamic partnership between the Foundation & industry leaders.
“We are proud to support the Rheumatology Research Foundation’s Journey to Cure initiative, which continues to foster ongoing education and innovative research within the rheumatology community,” says Jim Salanty, vice president, U.S. Rheumatology, AbbVie. “At AbbVie, in our ongoing rheumatology work, we share a passion for creating meaningful options for those living with rheumatic diseases and working in the field of rheumatology, and our relationship with the Foundation is a natural extension of this commitment.”
Another Leadership level donor, Amgen Inc., has made significant contributions to the success of the Journey to Cure campaign. Amgen was actually the first Leadership level donor on the Corporate Roundtable and continues to support the Foundation’s efforts to advance treatments and find cures. “Amgen is proud of its ongoing commitment to support the Journey to Cure campaign, including for the fellowship program, which helps ensure we have well-trained researchers working in the field to advance our understanding and treatment of rheumatic diseases,” says Brian Kotzin, MD, vice president of global development at Amgen. “This initiative helps to reinforce Amgen’s commitment to advancing rheumatology care for the benefit of patients worldwide.”
Other companies on the Corporate Roundtable are also taking part in Journey to Cure. Pfizer Inc., a Pinnacle level donor, has committed substantial financial support to the campaign. These groups are essential to discovering advancements in treating rheumatic diseases.
Patients and loved ones of individuals affected by rheumatic disease are also making significant commitments to Journey to Cure.
To them, supporting the Foundation and the campaign is also a way to invest in their own futures and the futures of others like themselves.
“As a patient, I want to see research into cures for rheumatic disease,” explains Bedford Vestal. “As a retired scientist, I know how hard it is for new researchers to acquire research funds to get their first projects started and prove themselves. We donate to support both these goals.”
